To include your compound in the COVID-19 Resource Center, submit it here.

Torque tops off $25M series A

On Nov. 14, immuno-oncology company Torque Therapeutics Inc. (Cambridge, Mass.) said

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE